Who owns PTC Therapeutics (PTCT)? Superinvestor holders

1 superinvestor of the 157 tracked here holds PTC Therapeutics (PTCT) in their latest 13F filing, a position of $13.5M. Louis Bacon gives it the most weight: 0.38% of the reported portfolio. In their latest reported quarter, Louis Bacon added.

Josef Lakonishok sold out of it in their latest quarter.

Hold it now
1
of 157 tracked
Combined value
$13.5M
Bought / sold
1 / 1
last quarter

Key facts

Superinvestors holding it
1 of 157
Biggest holder
Louis Bacon, $13.5M
Largest weight
Louis Bacon, 0.38%of their portfolio
Combined value
$13.5M
Bought last quarter
1
Sold last quarter
1

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding PTCT, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Louis BaconMoore Capital Management0.38%$13.5M208.55K▲ Added 176%+132.97KQ3 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of PTCT by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 2026921208.55K$13.5M11
Q2 2026157124.92K$2M10
Q1 20261570——02
Q4 20251570——00
Q3 20251570——00
Q2 20251570——01
Q1 202515611.37M$70M02
Q4 2024156120.4K$920.9K10

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of PTCT held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Louis Bacon208.55K———————
Polen Capital team—24.92K——————
Steve Cohen·—————1.37M—
Julian and Felix Baker·——————20.4K

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own PTCT?

In their latest 13F filings: Louis Bacon (0.38% of the portfolio, $13.5M).

Who bought PTCT last quarter?

Louis Bacon (added 176%). “Last quarter” is each investor's latest reported quarter.

Who sold PTCT last quarter?

Sold out entirely: Josef Lakonishok (was $57K).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns PTC Therapeutics (PTCT)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/PTCT/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to PTCT by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.